⌘K

Home/Filings/4/0001179110-18-014134

4//SEC Filing

Armour Alison A. 4

Accession 0001179110-18-014134

CIK 0001235007other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:13 PM ET

Size

13.7 KB

Accession

0001179110-18-014134

Insider Transaction Report

Form 4

Period: 2018-12-17

ENDOCYTE INCECYT

Armour Alison A.

Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2018-12-17$3.18/sh+14,212$45,194→ 150,252 total
Exercise/Conversion
Stock option (right to buy)
2018-12-17−1→ 39,999 total
Exercise: $2.16Exp: 2027-02-02→ Common Stock (1 underlying)
Exercise/Conversion
Stock option (right to buy)
2018-12-17−35,000→ 25,000 total
Exercise: $5.16Exp: 2025-07-31→ Common Stock (35,000 underlying)
Exercise/Conversion
Common Stock
2018-12-17$5.16/sh+35,000$180,600→ 136,040 total
Exercise/Conversion
Common Stock
2018-12-17$2.16/sh+1$2→ 150,253 total
Exercise/Conversion
Stock option (right to buy)
2018-12-17−14,212→ 45,788 total
Exercise: $3.18Exp: 2026-02-04→ Common Stock (14,212 underlying)

Footnotes (3)

[F1]Shares subject to this option vest 1/4 annually over a period of four years beginning July 31, 2016.
[F2]Shares subject to this option vest 1/4 annually over a period of four years beginning February 4, 2017.
[F3]Shares subject to this option vest 1/4 annually over a period of four years beginning February 2, 2018.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeother

Related Parties

1

filerCIK 0001646726

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 4:13 PM ET
Size: 13.7 KB

View on SEC.gov